Peripheral Vascular Devices | Market Insights | US | 2024
The US PV device market will be driven by the continued rise in adoption of various endovascular treatment techniques and innovative product launches supported by favorable reimbursement programs, which will spur modest growth through 2032. However, the market is expected to face some challenge from push for cost-effective PV intervention, which has brought about adverse updates to reimbursement rates for major procedure types within the US PV intervention space.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in the US from 2019 through 2032.
